The U.S. Food and Drug Administration announced that it awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over the next four years. These trial research grants, awarded through the Congressionally funded Orphan Products Grants Program, enhance the development of medical products for patients with rare diseases. Yourway fully understands the challenges conducting clinical trials for rare diseases, and provides a range of integrated solutions to overcome them.